TrialCancer immunology, immunotherapy : CII2010

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

James L Gulley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.